Oscar Health (OSCR) Stock Drops 9% Even As It Smashes Q2 Earnings
TLDR
- Oscar Health posted Q2 net income of $361.8 million, or $1.10 per share, versus a loss of 89 cents a year ago
- Revenue jumped 70% year over year to $4.88 billion, beating Wall Street’s $4.73 billion estimate
- Medical loss ratio improved to 79.2%, down from 91.1% in Q2 2025
- Full-year earnings from operations guidance raised to $500 million-$700 million, up from $250 million-$450 million
- OSCR stock fell roughly 9% on Thursday despite the beat, after an 8.9% premarket spike
Oscar Health posted one of its strongest quarters on record Thursday, but the stock had other ideas.
OSCR dropped about 9% during trading on August 6, reversing a near 9% premarket gain. The stock closed at $30.11 on Wednesday. Despite that drop, the stock is still up 110% in 2026, versus 13% for the S&P 500.
The company reported Q2 earnings of $1.10 per share, crushing the analyst consensus of 40 cents. Revenue surged 70% to $4.88 billion, ahead of the $4.73 billion Wall Street had expected.
OSCAR HEALTH $OSCR Q2’26 EARNINGS HIGHLIGHTS
… Continue reading the full article at the original source below.
This content is automatically aggregated. Full credit goes to the original publisher (coincentral.com).
